| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 712001 | Null | 0.0293341670043648 | -0.074306305 |
| NSC 724631 | 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.0309214021749421 | 0.070854909 |
| NSC 741942 | Null | 0.0309214021749421 | 0.0086035597 |
| NSC 756166 | GSK312948A | 0.0309214021749421 | 0.27498015 |
| NSC 756251 | GW559768X | 0.0309214021749421 | -0.13703765 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0309214021749421 | 0.095296167 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0309214021749425 | -0.050542691 |
| NSC 295641 | Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester | 0.0309214021749425 | 0.29127517 |
| NSC 324368 | 3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide | 0.0309214021749425 | 0.041652997 |
| NSC 329226 | 42179 | 0.0309214021749425 | 0.13245621 |